doi: 10.7501/j.issn.0253-2670.2025.19.011
Objective To investigate the phenylpropanoid and nitrogen-containing chemical components in the seeds of Lycium barbarum L. and evaluate the anti-tumor effects of these chemical components. Methods Silica gel, octadecylsilane-bonded silica gel, high-performance liquid chromatography (HPLC), and thin-layer chromatography (TLC) were systematically used for separation and purification. Ultraviolet (UV), infrared (IR), nuclear magnetic resonance (NMR), and mass spectrometry (MS) were employed for structural identification of the compounds. The MTT assay was applied to assess the inhibitory effects of the compounds on four types of tumor cells: mouse breast cancer cells (4T1), human lung adenocarcinoma cells (H1299), human hepatocellular carcinoma cells (HepG2), and human colon cancer cells (RKO). Results A total of 12 phenylpropanoid compounds and 8 nitrogen-containing compounds were isolated and identified from the 75% ethanol extract of Lycium barbarum L. seeds. These compounds were identified as follows: N-cis-feruloyltyramine (1), N-trans-feruloyltyramine (2), meliasendanin D (3), xylogranatinin (4), isoscopoletin (5), n-butyl pyroglutamate (6), butyl-2-pyrrolidinone-5-carboxylate (7), (−)-syringaresinol (8), β-hydroxypropenocoumarone (9), ω-hydroxypropioguaiacone (10), 7-(3-ethoxy-5-methoxyphenyl)propane-7,8,9-triol (11), 7-O-ethylguaiacylglycerol (12), (2S,3S)-lyciumamide D (13), 1-(β-D-ribofuranosyl)-1H-1,2,4-triazole (14), scopoletin (15), p-coumaric acid (16), uridine (17), 1-O-coumaroyl-β-D-glucopyranose (18), (+)-syringaresinol (19), and trans-p-hydroxyphenethyl ferulate (20). In vitro MTT experiments showed that most compounds exhibited varying degrees of anti-tumor activity with IC50 values ranging from 2.99 to 43.80 µmol/L. Conclusion Compounds 4, 6, 9, 11, 12, 14, 18 were isolated from Solanaceae plants for the first time, and compounds 3, 7, 10 were isolated from the genus Lycium for the first time. According to the in vitro MTT assay results: compounds 10, 13, 14, 16, and 19 showed inhibitory effects on 4T1 cells; compounds 1—4, 6, 7, 13, 14, 18, and 19 exhibited anti-proliferative activity against H1299 cells; compounds 3, 11, 12, and 15 inhibited HepG2 cells; and compounds 1, 3—5, 11, 12, 14, 15, 17, 18, and 20 displayed anti-proliferative activity against RKO cells.